• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素特异性蛋白酶 USP43 与 EGFR/PI3K/AKT 之间相互抑制环路的失衡驱动乳腺癌发生。

Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis.

机构信息

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.

出版信息

Cell Res. 2018 Sep;28(9):934-951. doi: 10.1038/s41422-018-0079-6. Epub 2018 Aug 22.

DOI:10.1038/s41422-018-0079-6
PMID:30135474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6123467/
Abstract

Hyperactivation of EGFR/PI3K/AKT is a prominent feature of various human cancers. Thus, understanding how this molecular cascade is balanced is of great importance. We report here that the ubiquitin-specific protease USP43 is physically associated with the chromatin remodeling NuRD complex and catalyzes H2BK120 deubiquitination. Functionally this coordinates the NuRD complex to repress a cohort of genes, including EGFR, which are critically involved in cell proliferation and carcinogenesis. We show that USP43 strongly suppresses the growth and metastasis of breast cancer in vivo. Interestingly, USP43 also exists in the cytoplasm, where it is phosphorylated by AKT, enabling its binding to the 14-3-3β/ε heterodimer and sequestration in the cytoplasm. Significantly, hyperactivation of EGFR/PI3K/AKT in breast cancer is associated with the cytoplasmic retention of USP43 and thus, the inhibition of its transcriptional regulatory function. Moreover, cancer-associated mutations of USP43 affect its subcellular localization and/or epigenetic regulatory functions. Nuclear USP43 is significantly reduced in breast carcinomas and is associated with EGFR accumulation and AKT hyperactivation. A low level of nuclear USP43 correlates with higher histologic grades and poor prognosis. Our study identifies USP43 to be an H2BK120 deubiquitinase and a potential tumor suppressor and reveals a reciprocally inhibitory loop between USP43 and EGFR/PI3K/AKT, whose imbalance drives breast carcinogenesis.

摘要

EGFR/PI3K/AKT 的过度激活是多种人类癌症的显著特征。因此,了解这种分子级联反应是如何平衡的具有重要意义。我们在这里报告称,泛素特异性蛋白酶 USP43 与染色质重塑 NuRD 复合物物理结合,并催化 H2BK120 的去泛素化。从功能上讲,这协调了 NuRD 复合物来抑制一组基因,包括 EGFR,这些基因在细胞增殖和癌变中起着至关重要的作用。我们表明,USP43 强烈抑制体内乳腺癌的生长和转移。有趣的是,USP43 也存在于细胞质中,在细胞质中它被 AKT 磷酸化,使其能够与 14-3-3β/ε 异二聚体结合并被隔离在细胞质中。重要的是,乳腺癌中 EGFR/PI3K/AKT 的过度激活与 USP43 的细胞质保留有关,从而抑制其转录调节功能。此外,USP43 的癌症相关突变会影响其亚细胞定位和/或表观遗传调节功能。USP43 在乳腺癌中的核表达显著减少,与 EGFR 积累和 AKT 过度激活有关。核 USP43 水平低与组织学分级较高和预后不良相关。我们的研究将 USP43 鉴定为 H2BK120 去泛素酶和潜在的肿瘤抑制因子,并揭示了 USP43 和 EGFR/PI3K/AKT 之间的相互抑制循环,其失衡驱动了乳腺癌的发生。

相似文献

1
Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis.泛素特异性蛋白酶 USP43 与 EGFR/PI3K/AKT 之间相互抑制环路的失衡驱动乳腺癌发生。
Cell Res. 2018 Sep;28(9):934-951. doi: 10.1038/s41422-018-0079-6. Epub 2018 Aug 22.
2
Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).金纳米颗粒偶联槲皮素通过抑制表皮生长因子受体/磷脂酰肌醇-3激酶/蛋白激酶B介导的信号通路诱导乳腺癌细胞系(MCF-7和MDA-MB-231)凋亡。
Cell Biochem Funct. 2017 Jun;35(4):217-231. doi: 10.1002/cbf.3266. Epub 2017 May 12.
3
Mutation of genes of the PI3K/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness.乳腺癌中PI3K/AKT信号通路基因的突变支持了它们作为乳腺癌侵袭性生物标志物的潜在重要性。
Virchows Arch. 2016 Jul;469(1):35-43. doi: 10.1007/s00428-016-1938-5. Epub 2016 Apr 8.
4
WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.WBP2下调通过阻断三阴性乳腺癌中的YAP转录和EGFR/PI3K/Akt信号通路抑制细胞增殖。
Cell Physiol Biochem. 2018;48(5):1968-1982. doi: 10.1159/000492520. Epub 2018 Aug 9.
5
USP43 promotes tumorigenesis through regulating cell cycle and EMT in breast cancer.USP43通过调节乳腺癌中的细胞周期和上皮-间质转化来促进肿瘤发生。
Int J Clin Exp Pathol. 2017 Nov 1;10(11):11014-11021. eCollection 2017.
6
(-)-Liriopein B Suppresses Breast Cancer Progression via Inhibition of Multiple Kinases.(-)-麦冬黄素B通过抑制多种激酶抑制乳腺癌进展。
Chem Res Toxicol. 2015 May 18;28(5):897-906. doi: 10.1021/tx500518j. Epub 2015 Apr 21.
7
Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.Skp2 依赖性 AKT 的再激活导致对 PI3K 抑制剂的耐药性。
Sci Signal. 2018 Mar 13;11(521):eaao3810. doi: 10.1126/scisignal.aao3810.
8
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.乳腺癌细胞中与激活的 ErbB 系统相关的内分泌抵抗可通过抑制 MAPK 或 PI3K/Akt 信号通路来逆转。
Int J Cancer. 2010 Jan 15;126(2):545-62. doi: 10.1002/ijc.24750.
9
Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.Akt/PKB 介导的 Twist1 磷酸化通过介导 PI3K/Akt 和 TGF-β 信号轴之间的串扰促进肿瘤转移。
Cancer Discov. 2012 Mar;2(3):248-59. doi: 10.1158/2159-8290.CD-11-0270. Epub 2012 Jan 25.
10
14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.14, 15-EET 通过上调整合素 αvβ3 并激活 FAK/PI3K/AKT 信号通路诱导乳腺癌细胞 EMT 和顺铂耐药。
J Exp Clin Cancer Res. 2018 Feb 9;37(1):23. doi: 10.1186/s13046-018-0694-6.

引用本文的文献

1
YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer.YY1诱导的USP43通过稳定脂肪酸合酶(FASN)并随后激活卵巢癌中的溶质载体家族7成员11(SLC7A11)来驱动铁死亡抑制。
Cell Death Dis. 2025 Sep 1;16(1):589. doi: 10.1038/s41419-025-07886-5.
2
AKT and DUBs: a bidirectional relationship.AKT与去泛素化酶:一种双向关系。
Cell Mol Biol Lett. 2025 Jul 7;30(1):77. doi: 10.1186/s11658-025-00753-3.
3
AKT kinases as therapeutic targets.AKT 激酶作为治疗靶点。
J Exp Clin Cancer Res. 2024 Nov 29;43(1):313. doi: 10.1186/s13046-024-03207-4.
4
A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway.深入探究去泛素化酶在缺氧诱导因子途径中的作用。
Biochem Soc Trans. 2024 Dec 19;52(6):2253-2265. doi: 10.1042/BST20230861.
5
Roles of deubiquitinases in urologic cancers (Review).去泛素化酶在泌尿系统癌症中的作用(综述)
Oncol Lett. 2024 Oct 14;28(6):609. doi: 10.3892/ol.2024.14743. eCollection 2024 Dec.
6
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches.泛素化和去泛素化在癌症中的作用:从机制到新的治疗方法。
Mol Cancer. 2024 Jul 25;23(1):148. doi: 10.1186/s12943-024-02046-3.
7
Deubiquitinating enzyme mutagenesis screens identify a USP43-dependent HIF-1 transcriptional response.去泛素化酶诱变筛选鉴定出 USP43 依赖性的 HIF-1 转录反应。
EMBO J. 2024 Sep;43(17):3677-3709. doi: 10.1038/s44318-024-00166-6. Epub 2024 Jul 15.
8
Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation.青蒿素逆转 ER+ 乳腺癌他莫昔芬耐药:生物信息学分析和实验验证。
Oncol Res. 2024 May 23;32(6):1093-1107. doi: 10.32604/or.2024.047257. eCollection 2024.
9
The mechanism of USP43 in the development of tumor: a literature review.USP43在肿瘤发生发展中的作用机制:文献综述
Aging (Albany NY). 2024 Apr 8;16(7):6613-6626. doi: 10.18632/aging.205731.
10
USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.USP43 通过稳定 c-Myc 促进膀胱癌中的糖酵解和转移。
Cell Death Dis. 2024 Jan 13;15(1):44. doi: 10.1038/s41419-024-06446-7.

本文引用的文献

1
USP9X regulates centrosome duplication and promotes breast carcinogenesis.USP9X 调控中心体复制并促进乳腺癌发生。
Nat Commun. 2017 Mar 31;8:14866. doi: 10.1038/ncomms14866.
2
Silibinin Treatment Inhibits the Growth of Hedgehog Inhibitor-Resistant Basal Cell Carcinoma Cells via Targeting EGFR-MAPK-Akt and Hedgehog Signaling.水飞蓟宾治疗通过靶向 EGFR-MAPK-Akt 和 Hedgehog 信号通路抑制 Hedgehog 抑制剂耐药的基底细胞癌细胞的生长。
Photochem Photobiol. 2017 Jul;93(4):999-1007. doi: 10.1111/php.12727. Epub 2017 Mar 6.
3
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.PI3K/AKT/mTOR:在乳腺癌进展、耐药性和治疗中的作用。
Cancer Metastasis Rev. 2016 Dec;35(4):515-524. doi: 10.1007/s10555-016-9637-x.
4
FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.FOXK2 引发大量转录抑制,并抑制低氧反应和乳腺癌发生。
Cancer Cell. 2016 Nov 14;30(5):708-722. doi: 10.1016/j.ccell.2016.09.010. Epub 2016 Oct 20.
5
Ubiquitin ligase RNF20/40 facilitates spindle assembly and promotes breast carcinogenesis through stabilizing motor protein Eg5.泛素连接酶 RNF20/40 通过稳定驱动蛋白 Eg5 促进纺锤体组装并促进乳腺癌发生。
Nat Commun. 2016 Aug 25;7:12648. doi: 10.1038/ncomms12648.
6
SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability.SIRT7 是一种组蛋白去琥珀酰酶,它在功能上与染色质紧缩和基因组稳定性相关联。
Nat Commun. 2016 Jul 20;7:12235. doi: 10.1038/ncomms12235.
7
USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.USP9X通过稳定XIAP来调节侵袭性B细胞淋巴瘤中的有丝分裂细胞死亡和化疗耐药性。
EMBO Mol Med. 2016 Aug 1;8(8):851-62. doi: 10.15252/emmm.201506047. Print 2016 Aug.
8
Deubiquitinases and cancer: A snapshot.去泛素化酶与癌症:简要概述。
Crit Rev Oncol Hematol. 2016 Jul;103:22-6. doi: 10.1016/j.critrevonc.2016.04.018. Epub 2016 May 6.
9
Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis.USP7介导的组蛋白去甲基化酶PHF8的稳定促进乳腺癌发生。
J Clin Invest. 2016 Jun 1;126(6):2205-20. doi: 10.1172/JCI85747. Epub 2016 May 16.
10
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms.与TP53缺失相关的缺失通过不依赖p53的机制驱动癌症。
Nature. 2016 Mar 24;531(7595):471-475. doi: 10.1038/nature17157. Epub 2016 Mar 16.